Primary diffuse large B-cell lymphoma of the central nervous system: A case report and literature review

被引:4
作者
Chen, Dawei [1 ]
Gu, Weihong [2 ]
Li, Wenzhong [1 ]
Liu, Xiaoliang [1 ]
Yang, Xiaoyu [1 ]
机构
[1] Jilin Univ, Hosp 1, Dept Neurosurg, Bldg 3,71 Xinmin St, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Hosp 2, Dept Surg, Changchun 130021, Jilin, Peoples R China
关键词
lymphoma; central nervous system tumor; diagnosis; treatment; PRIMARY CNS LYMPHOMA; INTRAVENOUS METHOTREXATE; IMMUNOCOMPETENT PATIENTS; THERAPY; BRAIN; TEMOZOLOMIDE; EXPERIENCE;
D O I
10.3892/ol.2016.4365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study reports the clinical diagnosis and management of a patient with primary diffuse large B-cell lymphoma (Bcl) of the central nervous system (CNS). Making an early diagnosis of primary diffuse large Bcl is challenging due to the variable and complicated clinical manifestations of the disease. The relevant literature was reviewed, and high-dose methotrexate, whole brain radiotherapy and highly active antiretroviral therapy was recommended for the patient. The present study elucidates the role of positron emission tomography-computed tomography scans for the diagnosis and management of primary diffuse large Bcl of the CNS, and demonstrates the importance of resection surgery in the management of the disease. Specifically, the present study proposes that resection surgery may be applied in the early stages of disease for patients with a single occupied lesion and increased intracranial pressure.
引用
收藏
页码:3085 / 3090
页数:6
相关论文
共 30 条
[1]   Treatment for primary CNS lymphoma: The next step [J].
Abrey, LE ;
Yahalom, J ;
DeAngelis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3144-3150
[2]  
Aki H, 2013, INT J CLIN EXP PATHO, V6, P1068
[3]   Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience [J].
Angelov, Lilyana ;
Doolittle, Nancy D. ;
Kraemer, Dale F. ;
Siegal, Tali ;
Barnett, Gene H. ;
Peereboom, David M. ;
Stevens, Glen ;
McGregor, John ;
Jahnke, Kristoph ;
Lacy, Cynthia A. ;
Hedrick, Nancy A. ;
Shalom, Edna ;
Ference, Sandra ;
Bell, Susan ;
Sorenson, Lisa ;
Tyson, Rose Marie ;
Haluska, Marianne ;
Neuwelt, Edward A. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3503-3509
[4]  
[Anonymous], 2008, WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues
[5]   Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma [J].
Barajas, R. F., Jr. ;
Rubenstein, J. L. ;
Chang, J. S. ;
Hwang, J. ;
Cha, S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (01) :60-66
[6]   Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma [J].
Basso, U ;
Brandes, AA .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (10) :1298-1312
[7]   Primary CNS Lymphoma in Immunocompetent Patients [J].
del Rio, Monica Sierra ;
Rousseau, Audrey ;
Soussain, Carole ;
Ricard, Damien ;
Hoang-Xuan, Khe .
ONCOLOGIST, 2009, 14 (05) :526-539
[8]   Primary CNS lymphoma [J].
Ferreri, Andres J. M. ;
Marturano, Emerenziana .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (01) :119-130
[9]  
Gerstner ER, 2010, ARCH NEUROL-CHICAGO, V67, P291, DOI 10.1001/archneurol.2010.3
[10]   High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary? [J].
Glantz, MJ ;
Cole, BF ;
Recht, L ;
Akerley, W ;
Mills, P ;
Saris, S ;
Hochberg, F ;
Calabresi, P ;
Egorin, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1561-1567